A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial

Journal of the American College of Cardiology

Volumn 34, Issue 7, 1999, Pages 1954-1962

  Ross, Allan M ^a   Coyne, Karin S ^a   Reiner, Jonathan S ^a   Greenhouse, Samuel W ^b   Fink, Cynthia ^a   Frey, Anthony ^a   Moreyra, Eduardo ^a   Traboulsi, Mouhieddin ^c   Racine, Normand ^d   Riba, Arthur L ^e   Thompson, Mark A ^f   Rohrbeck, Steven ^g   Lundergan, Conor F ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b George Washington Biostatistics Center   (United States)

^c FOOTHILLS HOSPITAL   (Canada)

^d NOTRE DAME HOSPITAL   (Canada)

^e OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^f ROCHESTER GENERAL HOSPITAL   (United States)

^g High Point Regional Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; PLACEBO;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART REINFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; COMBINED MODALITY THERAPY; CORONARY ANGIOGRAPHY; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; RECOMBINANT PROTEINS; RECURRENCE; SAFETY; STROKE VOLUME; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0033452337     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00444-1     Document Type: Article

References (37)

1. Grines G.L., Browne K.F., Marco J., et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 328:1993;673-679.
2. Zijlstra F., Jan de Boer M., Hoorntje J.C., et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 328:1993;680-684.
3. Gibbons R.J., Holms D.R., Reeder G.S., et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 328:1993;685-691.
4. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 336:1997;1621-1628.
5. Every N.R., Parsons L.S., Hlatky M., Martin J.S., Weaver W.D. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med. 335:1996;1253-1260.
6. O'Neill W.W., Weintraub R., Grines C.L., et al. A prospective, placebo-controlled, randomized trial of intravenous streptokinase and angioplasty versus lone angioplasty therapy of acute myocardial infarction. Circulation. 86:1992;1710-1717.
7. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction the TIMI II-A results . JAMA. 260:1988;2849-2858.
8. Comparison of invasive versus conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 320:1989;618-627.
9. Topol E.J., Califf R.M., George B.S., et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med. 371:1987;581-588.
10. Califf R.M., Topol E.J., Stack R.S., et al. Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Circulation. 83:1991;1543-1556.
11. Simoons M.L., Betriu A., Col J., et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction no additional benefit from immediate percutaneous coronary angioplasty . Lancet. 1:1988;197-203.
12. SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. BMJ. 302:1991;555-560.
13. Chesebro J.H., Knatterud G., Roberts R., et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I a comparison between intravenous tissue plasminogen activator and intravenous streptokinase . Circulation. 76:1987;142-154.
14. Cruikshank M.K., Levine M.N., Hirsh J., Roberts R., Siguenza M. A standard heparin nomogram for the management of heparin therapy. Arch Intern Med. 151:1991;333-337.
15. Douglas J.S., Pepine C.J., Block P.C., et al. Recommendations for development and maintenance of competence in coronary interventional procedures. J Am Coll Cardiol. 22:1993;629-631.
16. Dodge H.T., Saddler H., Ballew D.W., Lord J.D. The use of biplane angiocardiography for the measurement of left ventricular volume in man. Am Heart J. 60:1960;762-776.
17. Bolson E.L., Kliman S., Sheehan F., Dodge H.T. Computers in Cardiology. Left ventricular segmental wall motion - a new method using local direction information. 1980;245-248 IEEE Computer Society Press, Long Beach, CA.
18. Ross A.M. New plasminogen activators a clinical review . Clin Cardiol. 22:1999;165-171.
19. The effects of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med. 329:1993;1615-1622.
20. Outcome of attempted rescue coronary angioplasty after failed thrombolysis for acute myocardial infarction. Am J Cardiol. 74:1994;172-174.
21. Ross A.M., Lundergan C.F., Rohrbeck S.C., et al. Rescue angioplasty following thrombolysis technical and clinical outcomes in a large thrombolysis trial . J Am Coll Cardiol. 31:1998;1511-1517.
22. Ellis S.G., da Silva E.R., Heyndrickx G., et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. Circulation. 90:1994;2280-2284.
23. Gorfinkel H.J., Berger S.M., Klaus A.P., et al. Rescue angioplasty in failed thrombolysis in acute myocardial infarction a community hospital experience . J Invas Cardiol. 9:1997;83-87.
24. Abbottsmith C.W., Topol E.J., George B.S., et al. Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty. J Am Coll Cardiol. 16:1990;770-778.
25. Liem A.L., van't Hof A.W., Hoorntje J.C., et al. Influence of treatment delay on infarct size and clinical outcome in patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol. 32:1998;629-633.
26. Newby L.K., Rutsch W.R., Califf R.M., et al. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol. 27:1996;1646-1655.
27. Milavetz J.J., Giebel D.W., Christian T.F., Schwartz R.S., et al. Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol. 31:1998;1246-1251.
28. Weaver W.D., Cerqueira M., Hallstrom A.P., et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. JAMA. 270:1993;1211-1216.
29. The National Registry for Myocardial Infarction-2 (Database) (1998). Genentech, Inc., South San Francisco, CA.
30. Morgan C.D., Roberts R.S., Hag A.M., et al. Coronary artery patency, infarct size, and left ventricular function after thrombolytic therapy for acute myocardial infarction results from the tissue plasminogen activator: Toronto (TPAT) placebo-controlled trial . J Am Coll Cardiol. 17:1991;1451-1457.
31. Vogt A., von Essen R., Tebbe U., et al. Impact of early reperfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction retrospective analysis of four German multicenter studies . J Am Coll Cardiol. 21:1993;1391-1395.
32. Ross A.M., Coyne K.S., Moreya E., et al. The extended mortality benefit of early postinfarction reperfusion. Circulation. 97:1998;1549-1556.
33. Topol E.J., Burek K., O'Neill W.W., et al. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med. 318:1988;1083-1088.
34. Rogers W.J., Bowlby L.J., Chandra N.C., et al. Treatment of myocardial infarction in the United States (1990 to 1993) observations from the National Registry of Myocardial Infarction . Circulation. 90:1994;2103-2114.
35. Every N.R., Parsons L.S., Fihn S.D., et al. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. Circulation. 96:1997;1770-1775.
36. Liem A.L., Zijlstra F., Hoorntje J., et al. Randomized trial of high-dose heparin before primary angioplasty in acute myocardial infarction the Heparin in Early Patency (HEAP) study (abstr) . Circulation. 17:(Suppl):1998;I767.
37. Antman E.M., Giugliano R.P., Gibson C.M., et al. Abciximab facilitates the rate and extent of thrombolysis results of the Thrombolysis in Myocardial Infarction (TIMI) 14 trial . Circulation. 99:1999;2720-2732.